N. Hirota
Research Subjects
Research Interests
N. Hirota has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
K. Ito
Bioresources Research and Development Laboratories, Sapporo Breweries Ltd, 37‐1 Nitta‐Kizaki, Ota, Gunma 370‐0393, Japan, E‐mail
3 shared publicationsK. Takeda
Research Institute for Bioresources, Okayama University, 2‐20‐1 Chuo, Okayama 710‐0046, Japan
3 shared publicationsT. Kaneko
Bioresources Research and Development Laboratories, Sapporo Breweries Ltd, 37‐1 Nitta‐Kizaki, Ota, Gunma 370‐0393, Japan, E‐mail
3 shared publicationsH. Kaneda
Frontier Laboratories of Value Creation, Sapporo Breweries, Ltd., 10 Okatome, Yaizu, Shizuoka 425‐0013, Japan
2 shared publicationsH. Kuroda
Frontier Laboratories of Value Creation, Sapporo Breweries, Ltd., 10 Okatome, Yaizu, Shizuoka 425‐0013, Japan
2 shared publicationsM. Takashio
Frontier Laboratories of Value Creation, Sapporo Breweries, Ltd., 10 Okatome, Yaizu, Shizuoka 425‐0013, Japan
2 shared publications
Latest Publications
- 25 May 2006
- Published by Wiley in Plant Breeding
- Vol. 125 (3) , 231-235
Mapping a factor controlling the thermostability of seed lipoxygenase-1 in barley
- 25 May 2006
- Published by Wiley in Plant Breeding
- Vol. 125 (3) , 231-235
Mapping a factor controlling the thermostability of seed lipoxygenase-1 in barley
- 15 May 2006
- Published by Wiley in Cereal Chemistry
- Vol. 83 (3) , 250-254
Brewing Performance of Malted Lipoxygenase‐1 Null Barley and Effect on the Flavor Stability of Beer
We examined the malting and brewing performances of a lipoxygenase‐1 (LOX‐1) null line of barley (Hordeum vulgare L.). The LOX‐normal malt and the LOX‐null malt were prepared from F4 populations derived from a single cross. We could not observe any major differences in the general malt characteristics between the two malts. A brewing trial was performed using these malts. The analysis of the wort and beer revealed that the absence of LOX‐1 had little effect on the general characteristics of the wort and beer. In contrast, beer made from the LOX‐null malt showed reduced levels of beer‐deteriorating substances, trans‐2‐nonenal (T2N), and trihydroxyoctadecenoic acid (THOD). In the sensory evaluation, well‐trained panel members recognized the significant superiority of the aged LOX‐null beer in terms of staleness. These results show that the LOX‐1 null barley line can be effectively used to improve the flavor stability of beer without changing the other important beer qualities.
- 15 May 2006
- Published by Wiley in Cereal Chemistry
- Vol. 83 (3) , 250-254
Brewing Performance of Malted Lipoxygenase‐1 Null Barley and Effect on the Flavor Stability of Beer
We examined the malting and brewing performances of a lipoxygenase‐1 (LOX‐1) null line of barley (Hordeum vulgare L.). The LOX‐normal malt and the LOX‐null malt were prepared from F4 populations derived from a single cross. We could not observe any major differences in the general malt characteristics between the two malts. A brewing trial was performed using these malts. The analysis of the wort and beer revealed that the absence of LOX‐1 had little effect on the general characteristics of the wort and beer. In contrast, beer made from the LOX‐null malt showed reduced levels of beer‐deteriorating substances, trans‐2‐nonenal (T2N), and trihydroxyoctadecenoic acid (THOD). In the sensory evaluation, well‐trained panel members recognized the significant superiority of the aged LOX‐null beer in terms of staleness. These results show that the LOX‐1 null barley line can be effectively used to improve the flavor stability of beer without changing the other important beer qualities.
- 14 October 2005
- Published by Springer Nature in Theoretical and Applied Genetics
- Vol. 111 (8) , 1580-1584
Characterization of lipoxygenase-1 null mutants in barley
- 14 October 2005
- Published by Springer Nature in Theoretical and Applied Genetics
- Vol. 111 (8) , 1580-1584
Characterization of lipoxygenase-1 null mutants in barley
- 1 September 1986
- Vol. 27 (9) , 1661-7
[Diminished bone marrow fibrosis on autopsy in a patient with acute myelofibrosis following chemotherapy].
- 1 September 1986
- Vol. 27 (9) , 1661-7
[Diminished bone marrow fibrosis on autopsy in a patient with acute myelofibrosis following chemotherapy].